1Sylvester RJ,van der Meijden AP,Oosterlinck W,et al.Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables:a combined analysis of 2596 patients from seven EORTC trials.Eur Urol,2006,49:466-477.
2Sivalingam S,Probert JL,Schwaibold H.The role of repeat transurethral resection in the management of high-risk superficial transitional cell bladder cancer.BJU Int,2005,96:7597-7562.
6Huang X, Wong MK, Zhao Q, et al. Soluble recombinant endostatin purified from Escherichia coli: antiangiogenic activity and antitumor effect. Cancer Res,2001, 15: 478-481.
7Eder JP Jr, Supko JGS, Clark JW, et al. Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily. J Clin Oncol, 2002,20:3772-3784.
8Robe PA, Nguyen-Khac MT, Lambert F, et al. Sulfasalazine unveils a contact-independent HSV-TK/gancielovir gene therapy bystander effect in malignant gliomas. Int J Oncol, 2007,30: 283 -290.
9Degtyar P, Neulander E, Zirkin H, et al. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology, 2004, 63 : 398-401.
10Tsukamoto M, Matsuyama H, Obaket, et al. Numerical aberration of chromosome 9 in bladder cancer: a possible prognostic marker for early tumor recurrence. Cancer Genet Cytogenet, 2002, 134: 41-45.
3Caruso G, Salvaggio G, Campisi A, et al. Bladder tumor staging: comparison of contrast-enhanced and gray-scale ultrasound. A JR Am J Roentgenol, 2010, 194:151-156.
4Verma S, Rajesh A, Prasad SR, et al. Urinary bladder cancer: role of MR imaging. Radiographics, 2012, 32:371-387.
5Cheng L, MacLennan GT, Lopez-Beltran A. Histologic grading of urothelial carcinoma : a reappraisal. Hum Pathol, 2012, 43 : 2097- 2108.
6Mouli S, Casalino DD, Nikolaidis P. Imaging features of common and uncommon bladder neoplasms. Radiol Clin North Am, 2012, 50:301-316.
7Kobayashi S, Koga F, Yoshida S, et al. Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer:potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radial, 2011, 21:2178-2186.
8Takeuchi M, Sasaki S, Ito M, et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologie grade. Radiology, 2009, 251:112-121.
9Rosenkrantz AB, Mussi TC, Spieler B, et al. High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging, 2012, 35:1478-1483.
10Aveu S, Koseoglu MN, Ceylan K, et al. The value of diffusion- weighted MRI in the diagnosis of malignant and benign urinary bladder lesions. Br J Radiol, 2011, 84:875-882.
